Nurse Call Systems Market Set to Surpass US$ 4.55 Billion by 2033

Nurse Call Systems Market
Nurse Call Systems Market

The nurse call systems market growth is anticipated to expand at a consistent CAGR of 8.8% throughout the course of the projected period. The market is projected to be valued US$ 4.55 billion by 2033, from its 2023 valuation of US$ 1.96 billion.

The market for nurse call systems, which is well-positioned to meet the evolving needs of healthcare institutions, is seeing notable developments. The growth of this industry indicates a commitment to enhancing patient care and interprofessional communication in healthcare settings. Nurse call systems market sales are critical for accelerating patient-provider communication, which improves reaction times and overall efficacy. This is because of their state-of-the-art features and technology.

  • The high penetration of digitization in healthcare facilities is contributing to the sales of nurse call appliances. Furthermore, the demand for effective communication between patients, guardians, and healthcare staff is propelling the market growth.
  • Governments increasing their healthcare budget post-pandemic is fueling the demand for nurse call devices. The new wired nurse call systems are gaining traction in the market space as they are cheap and more convenient to use.
  • Private healthcare entities are advancing their digital communications bands with artificial intelligence and machine learning and are expected to thrive in sales.
  • The rising number of hospitals and clinics along with the integration of wireless technology along with increasing research and development programs are fueling the market growth.

Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-12404

Key Points

  1. The United America market is likely to lead the nurse call systems market in terms of market share and CAGR. The market is expected to thrive at a leading CAGR of 7.9% between 2023 and 2033. The market growth is attributed to the high healthcare budget and enhanced hospital infrastructure. The regional market is likely to cross a value of US$ 527.8 million by 2033.
  2. China nurse call systems market is another significant nurse call systems market. The regional growth is attributed to the increased number of private hospitals and healthcare clinics. The regional market is anticipated to expand at a CAGR of 7.4% during the forecast period while it is expected to hold a value of US$ 128.4 million by 2033.
  3. The integrated communication systems segment is likely to thrive in the equipment size category as it strives at a CAGR of 8.4% during the forecast period. The growth is attributed to factors like high convenience and patient connectivity
  4. The hospital segment is expected to top the end user type category as it secures a CAGR of 8.1% between 2023 and 2033.

Competitive Landscape:

The key vendors focus on integrating call systems with artificial intelligence and high bandwidth. Furthermore, rapid digitization in the healthcare sector is providing opportunities to vendors.

The Key competitors also merge, acquire, and partner with other companies to increase their supply chain, and distribution channel. The key players working in the market are: Proofpoint, Digital Shadows Ltd, FireEye, LookingGlass Cyber Solutions, RSA Security LLC, PhishLabs, Axur, Blueliv, and CYBERSPRINT.

Request Report Methodology:https://www.futuremarketinsights.com/request-report-methodology/rep-gb-12404

Recent Market Developments:

  • Stanley Healthcare added the UL 1069 Arial Nurse Call that is loaded with a Wi-Fi network, and 2-way voice communication between residents and caregivers. The product comes with staff notifications and central staff alerting system to provide the necessary features for every level of care.
  • Forbix Semicon has introduced its wireless nurse call systems with a nurse call bell with LCD VGA monitor and an inbuilt 24×7 data logger.

Key Segments:

Equipment Type:

  • Button-based Systems
  • Integrated Communication Systems
  • Mobile Systems
  • Intercom Systems

Application:

  • Alarms & Communications
  • Workflow Optimization
  • Wanderer Control
  • Fall Detection & Prevention

Technology:

  • Wired Nurse Call Systems
  • Wireless Nurse Call Systems

End-user:

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Long-term Care Centers

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific (APAC)
  • The Middle East & Africa (MEA)

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Therapeutic Apheresis Market is anticipated to achieve a worth of US$ 5,264.4 Million by 2033, growing at a CAGR of 6.8%

Therapeutic Apheresis Market
Therapeutic Apheresis Market

According to forecasts, the global therapeutic apheresis market trends is expected to be US$ 2,717.9 million in 2023 and US$ 5,264.4 million by 2033, the demand for therapeutic apheresis is estimated to rise at a CAGR of 6.8% during the forecast period.

The rising prevalence of diseases, increased demand for blood components, and the safety that goes along with them are the key components for market growth. Moreover, technological advancements in creating new apheresis techniques and increasing reimbursement policies and funding for apheresis procedures are the market-driving forces.

Request A Sample Copy Of This Research Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-5863

Also, the market expansion is anticipated to be fueled by the increased incidence of blood-related illnesses, the availability of supportive government initiatives, and reimbursement frameworks. Moreover, it is projected that the demand for apheresis equipment is supported throughout the forecast period by the increased popularity and involvement in blood donation campaigns and camps and the rising number of blood transfusions.

The expansion of the North American therapeutic apheresis industry is anticipated to be constrained by the need for more donor availability and histocompatibility. For instance, barely 3% of Americans give blood, according to a June 2019 article from the American Red Cross.

Key Takeaways:

  • By 2033, the therapeutic apheresis industry in the United Kingdom is likely to expand, with a CAGR of 4.8%.
  • In 2022, the United States developed the therapeutic apheresis business with a share of 28.8%.
  • The therapeutic apheresis industry grew considerably to US$ 2,577.9 million in 2022.
  • The therapeutic apheresis sector expanded at a CAGR of 4.4% from 2018 to 2022.
  • By 2033, China’s therapeutic apheresis industry is projected to develop with a CAGR of 8.3%.
  • By 2033, India’s therapeutic apheresis industry is projected to expand with a CAGR of 6.8%.
  • Japan’s therapeutic apheresis industry grew significantly, with a 4.2% share in 2022.
  • Australia’s therapeutic apheresis industry is likely to expand with a CAGR of 6.1% by 2033.
  • Germany’s therapeutic apheresis business grew, with a share of 6.3% in 2022.
  • In 2022, based on the technology, centrifugation dominated the market, with a share of 58.3%.
  • In 2022, the blood bank segment dominated the market, with a share of 43.5%, based on end users.

Competitors Winning Strategies:

The market has currently demonstrated budding success and is well-established in several locations. As a result of growing government activities, more individuals are becoming aware of the industry under study, fueling its expansion. Strategic partnerships and new product launches by large corporations are also anticipated to fuel market expansion.

Embrace Smarter Choices With Our Methodology-Derived Insights: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-5863

Recent Developments:

  • The TORAYMYXIN medical device was introduced to the European market by Toray Medical Co. Ltd. (Japan) in June 2019.
  • Baxter International Inc. (United States) introduced the PrisMax system in the US in July 2019.
  • In June 2022, Terumo Blood and Cell Technologies announced that the automated red blood cell exchange procedure performed on the company’s Spectra Optia Apheresis System had been selected by the NHS MedTech Funding Mandate (MTFM) programme in NHS England in the United Kingdom to treat sickle cell disease.
  • In July 2022, Eliaz Therapeutics and Terumo Blood and Cell Technologies worked together to create and market a breakthrough therapeutic apheresis therapy for acute renal damage (AKI).

Key Players:

  • Asahi Kasei Medical Co.
  • Haemonetics Corporation
  • Miltenyi Biotec
  • Cerus Corporation
  • Terumo BCT Inc.
  • Fresenius Kabi USA
  • Terumo Bct
  • B. Braun Melsungen AG
  • Nikkiso Co. Ltd.
  • Medica S.p.A.
  • Baxter Healthcare Corporation
  • Kawasumi Laboratories Inc.
  • Therakos Incorporation

Act Now to Explore In-Depth Market Analysis: Purchase Now to Access Premium Information: https://www.futuremarketinsights.com/checkout/5863

Key Segments:

By Procedure Types:

  • Therapeutic Plasma Exchange (TPE)
  • Red Blood Cell Exchange (RBCX)
  • Cellular Depletions

By Technology:

  • Centrifugation
  • Membrane filtration

By Application:

  • Hematology
  • Neurology
  • Nephrology
  • Rheumatology
  • Oncology
  • Others

By End User:

  • Hospitals
  • Blood banks
  • Specialty clinics

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • MEA
  • Europe

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Enteral Feeding Devices Market Poised to Surpass US$ 4.1 Billion Milestone by 2033

Enteral Feeding Devices Market
Enteral Feeding Devices Market

The enteral feeding devices market sales is anticipated to develop at a 4.0% CAGR during the forecast period. By 2023, the market is projected to be valued US$ 2.8 billion, and by 2033, US$ 4.1 billion.

According to a new industry analysis published by Future industry Insights (FMI), the worldwide enteral feeding device market is expected to grow substantially in terms of value between 2020 and 2030. Every year, about a million new instances of stomach cancer are discovered, according to the US National Library of Medicine National Institutes of Health. Among the unpleasant side symptoms of the illness are indigestion, nausea, and abdominal pain, which make it more challenging to eat as directed.

The demand for enteral feeding devices is rising in direct proportion to the number of cases since these devices help administer food either orally or directly through the small intestine. The rising prevalence of irritable bowel syndrome (IBS), perianal infections, diverticulitis, and hemorrhoids, in addition to stomach cancer, is positively affecting the need for enteral feeding systems.

Get access to your Sample Report for more information:https://www.futuremarketinsights.com/reports/sample/rep-gb-12403

Similar to this, the growing geriatric population is driving up demand for enteral feeding equipment. The use of enteral feeding systems is necessary due to the high frequency of chronic diseases among the elderly population, which makes it challenging to eat.

“While hospitals remain a lucrative end-use segment, manufacturers are focusing catering to the growing demand in homecare settings by maintaining the optimal prices” opines FMI analyst.

Enteral Feeding Devices Market — Key Takeaways :

  • The global enteral feeding devices market will expand at a healthy CAGR of 6.6% through 2030 and will surge past valuation of US$ 6 Bn.
  • Among applications, oncology is expected to drive the majority of demand for the devices as consumption of food naturally becomes onerous due to chemotherapy sessions.
  • Feeding pumps are expected to remain the most sought-out product types, gaining traction among more than 6 out of the 10 healthcare providers worldwide.
  • Nasoenteric tubes are gaining prominence among healthcare institutions, owing to their efficiency in administering nutrients to patients suffering from neurological disorders, dementia, and lateral sclerosis.
  • Although hospitals remain the leading end-users, the home care settings segment is forecasted to account for a significant share in the market value.

Enteral Feeding Devices Market — Key Trends

  • COVID-19 is expected to catalyze the growth of the market as a result of the infection which comprises the patient’s ability to intake solid food, thus asserting medical professionals to administer enteral feeding.
  • With the weight of the enteral feeding devices being a major limitation, manufacturers are now focusing on developing lightweight products to transmute the restrain into opportunity.

Request Report Methodology:https://www.futuremarketinsights.com/request-report-methodology/rep-gb-12403

Enteral Feeding Devices Market — Regional Analysis

  • North America and Europe are expected to cumulatively account for nearly 70% of overall market value, with the former holding 40% of the share.
  • The dominance of these regions is attributed to favorable medical policies and the strong presence of market players.
  • Asia Pacific is forecasted to register tremendous growth on the back of rising healthcare expenditure, the presence of a large patient pool, and a burgeoning number of preterm births.

Enteral Feeding Devices Market — Competitive Landscape

Major market players operating in the market include ICU Medical, Boston Scientific Corporation, Fresenius Kabi, Abbott Laboratories, Cook Medical, Cardinal Health, Inc., Becton Dickinson & Company, and Dynarex Corporation among others. Market players are focusing on developing innovative products with low weight to increase portability.

On these lines, Infinity Feeding Pumps launched the Zevex EnteraLite Infinity Feeding Pump, which weighs less than one pound.

Enteral Feeding Devices Market — Taxonomy

Product Type:

  • Enteral Feeding Pumps
  • Enteral Feeding Tubes

Enterostomy Feeding Tubes

  • Standard Tubes
  • Standard Gastrostomy Tubes
  • Standard Jejunostomy Tubes
  • Standard Gastrojejunostromy Tubes
  • Low Profile Tubes
  • Low-profile Gastrostomy Tubes
  • Low-profile Jejunostomy Tubes
  • Nasoenteric Feeding Tubes
  • Nasogastric Feeding Tubes
  • Nasojejunal Feeding Tubes
  • Nasoduodenal Feeding Tubes

Oroenteric Feeding Tubes:

  • Administration Sets
  • Enteral Syringes
  • Consumables

Application

  • Oncology
  • Gastroenterology
  • Diabetes
  • Neurological Disorders
  • Others

Age Group

  • Adult
  • Pediatric
  • End-user

Hospitals

  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Homecare Settings
  • Others

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Mobile Speech Recognition Software Market Surging at a 22.5% CAGR, Anticipated to Hit US$ 25.4 Billion by 2032

The mobile speech recognition software market is projected to develop at a CAGR of 22.5% from 2022 to 2032, reaching a value of US$ 3.3 billion in 2022 and US$ 25.4 billion by 2032.

In enterprise applications, increasing adoption of conversational user interface (CUI) as a more prolific way to communicate among mobile devices like smartphones, tablets, etc. The proliferation of smartphones with advanced features and the development of voice-based applications is penetrating the demand for mobile speech recognition technologies positively.

Furthermore, several developments in the creation of cutting-edge algorithms and the processing capacity of modern smartphones will aid in providing effective voice recognition.

Request Sample Copy of Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-5961

Mobile Speech Recognition Software Market: Drivers and Restraints

A crucial requirement of biometric authentication in mobile banking is leading to the intensified integration of speech authentication, thus driving the market for Mobile Speech Recognition Software. Moreover, rising awareness of the multi-functionality of mobile devices in speech recognition technologies is also turning up as another important factor driving the growth of the market positively.

Lack of accuracy in noisy working environments is an important restraint, faced by most of the vendors in the Mobile Speech Recognition Software market.

Global Mobile Speech Recognition Software Market: Regional Outlook

Based on geography, the Mobile Speech Recognition Software market can be segmented into seven key regions namely North America, Latin America, Western Europe, Eastern Europe, APEJ, Japan, and Middle East & Africa.

Among various regions, the Mobile Speech Recognition Software market in North America is expected to dominate the market during the forecast period. Asia Pacific region will witness high growth, as increasing awareness among consumers and the low cost of biometric devices will boost the demand for Mobile Speech Recognition Software in a positive manner.

Key Players:

  • Nuance Communications Inc
  • Alphabet Inc
  • Apple Inc
  • Baidu Inc
  • Amazon Inc
  • Microsoft Corporation
  • VoiceBox Technologies Corporation
  • LumenVox, LLC
  • Pareteum Corporation, Sensory
  • ReadSpeaker Holding B.V.
  • VoiceVault Inc.

Seize this Opportunity: Buy Now for a Thorough Report
https://www.futuremarketinsights.com/checkout/5961

Key Segmentation:

By Vertical:

  • Healthcare
  • Military
  • Automotive
  • Retail
  • Government
  • Education
  • BFSI
  • Others

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • Middle East and Africa
  • Europe

About Future Market Insights (FMI):

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Multiple Unit Pellet Systems Market is poised to attain a valuation of US$ 5.2 Billion by 2033

Multiple Unit Pellet Systems Market
Multiple Unit Pellet Systems Market

The global multiple unit pellet systems market has experienced significant growth, reaching a valuation of US$ 3.6 billion in 2023. Projections indicate a steady upward trajectory, with an anticipated value of US$ 5.2 billion by the end of 2033, reflecting a Compound Annual Growth Rate (CAGR) of 3.6%.

Multiple Unit Pellet Systems (MUPS) offer a revolutionary approach to drug delivery, particularly in capsule form, enhancing physicochemical stability and improving ease of ingestion compared to traditional suspensions. Comprising pellets, granules, microcapsules, microspheres, and minitablets, MUPS represents a versatile and highly bioavailable dose form, providing a convenient alternative to conventional tablets.

Get Sample Copy of Latest Reports: https://www.futuremarketinsights.com/reports/sample/rep-gb-15446

The key advantage of MUPS lies in its user-friendly design, addressing challenges associated with traditional tablets. Patients often find MUPS easier to swallow, making them a preferred choice for enhanced medication adherence. Additionally, MUPS contribute to improved physicochemical stability, ensuring the efficacy of the drug throughout its shelf life.

The pharmaceutical industry is witnessing a paradigm shift towards innovative drug delivery systems, and MUPS are positioned as a frontrunner in this evolution. As healthcare professionals and patients alike recognize the benefits of MUPS, the industry is poised for substantial expansion over the forecast period.

FMI, a leading player in the pharmaceutical industry, is actively contributing to the growth and development of multiple unit pellet systems. With a commitment to innovation and excellence, FMI continues to explore new avenues in drug delivery technology, ensuring the advancement of patient-centric solutions.

Regional Outlook:

The multiple unit pellet systems industry in North America was controlled by Americans. Due to the rising incidence of gastrointestinal disorders and the rising need for gastro-resistant medications, market growth in the United States is predicted to soar throughout the projected period.

India may have strong CAGR growth between 2023 and 2033. India’s manufacturers are investing more in research and development due to the demand for improved pharmaceuticals.

During the anticipated period, China is anticipated to have significant expansion in the East Asia multiple unit pellet systems industry. As a result of its effective drug production, China sells medicines for incredibly low prices.

Key Takeaways:

  • The extended-release dosage form segment in the formulation category to grab a share of 47.23% from 2023 to 2033.
  • In the dosage form category, the capsules segment acquired a market share of 47.31% between 2023 and 2033.
  • The United States multiple unit pellet systems business to acquire a share of 27% by 2023.
  • The Germany MUPS industry is to grab a share of 5.2% by 2023.
  • Japanese multiple unit pellet systems (MUPS) market to hold a share of 5.6% by 2023.
  • Australia MUPS market to acquire a share of 1.8% by 2023.
  • Chinese multiple unit pellet systems business to expand at a CAGR of 4.4% through 2033.
  • India multiple unit pellet systems industry is to develop at a CAGR of 5.6% from 2023 to 2033.
  • United Kingdom MUPS market to evolve at a CAGR of 3.9% through 2033.
  • The North America MUPS industry to grab a share of 29.6% by 2023.
  • Europe multiple unit pellet systems industry to hold a share of 25.9% by 2023.

Uncover Hidden Opportunities With Our Proven Methodology: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-15446

Competitive Landscape:

Companies are working on obtaining fast-track drug approvals in an effort to diversify their product offerings and establish a strong presence in the multiple unit pellet systems industry.

To increase their market share, these multiple unit pellet systems manufacturers are engaging in several crucial strategies, such as mergers and acquisitions, new product launches, collaborations, research and development expenditure, distribution network expansion, and partnerships.

Companies offer their goods through a variety of channels, including e-commerce websites, retailers, distributors, corporate websites, and final customers.

Recent Development:

  • In May 2023, PERRIGO reported that the United States FDA had approved the 20 mg over-the-counter (OTC) mini capsules of meprobamate magnesium. To cure persistent heartburn, take this pill. The item is to be offered for sale under the retailer’s store brand, which is similar to Prilosec OTC.

Vital Multiple Unit Pellet System Manufacturers:

  • AstraZeneca plc
  • Merck KGaA
  • Janssen Pharmaceuticals, Inc. (Johnson & Johnson)
  • Galderma SA
  • Novartis AG
  • GlaxoSmithKline Plc
  • Perrigo Company Plc.
  • Cipla Ltd.
  • Astellas Pharma Inc.
  • Takeda Pharmaceutical Company Ltd.
  • Eli Lilly and Company
  • Dr. Reddy’s Laboratories Ltd.
  • Endo International Inc.
  • Mylan Pharmaceuticals Inc.
  • Teva Pharmaceuticals Ltd.
  • AbbVie (Allergan)
  • GlaxoSmithKline Plc
  • Bayer AG

Act Now to Explore In-Depth Market Analysis: Purchase Now to Access Competitive Analysis: https://www.futuremarketinsights.com/checkout/15446

Key Segments:

By Formulation:

  • Extended Release Dosage Form
  • Delayed Release Dosage Form
  • Delayed Release Orodispersible Dosage Form
  • Others

By Dosage Form:

  • Tablets
  • Capsules
  • Sachets
  • Others

By Drug Class:

  • Anti-Hypertensive
  • Proton Pump Inhibitors
  • Antibiotics
  • Analgesics
  • Others

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Patient Lateral Transfer Market Charts 9.2% CAGR from 2022 to 2030, Promising a Seamless Journey

Patient Lateral Transfer Market
Patient Lateral Transfer Market

The patient lateral transfer market trends is seeing a paradigm shift in patient care, with a focus on simple and safe transfers within medical facilities. This industry offers cutting-edge solutions that improve patient mobility and lower the possibility of accidents during lateral transfers. The global market for patient lateral transfers is anticipated to reach US$ 2 billion by the end of 2030, growing at a 9.2% CAGR.

It is impossible to completely rule out the possibility that patients moving and being lifted off of stretchers or beds will result in back injuries, pressure on carers, and awkward posture for healthcare professionals.

Patient lateral transfer devices come to the rescue over here.

Patient lateral transfer devices lessen friction during transfer of patients and prove to be equally beneficial for patients.

Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-12381

Key Takeaways

  • Air-assisted transfer devices held the largest market share in 2019 and the winning streak is expected to continue in the forecast period
  • Asia-Pacific is looked upon as a promising market due to growing awareness about the need for patient lateral transfer devices along with improvement in healthcare infrastructure
  • Covid-19 to escalate the market in the year 2020, and further traction expected with the onslaught of chronic devices
  • Individual product promulgation is a key trend observed in the market

Key Participant Insights

The global patient lateral transfer market exhibits higher growth potential along with key players projecting their brands.

The competitive factors include product differentiation, technology, and competitive pricing.

For instance – McAuley Medical’s Gold Rollboard, Patient Mover Slide Boards, and Handy Rollerboard Accessories, HoverMatt Air Transfer System from HoverTech, Himm-Rom’s HandyTube Manual Transfer Aid and Patient Transfer Board are doing the rounds at present.

The other players are also in the race. As such, there exists fierce competition over here. If players opt for partnerships/joint ventures, the competitive landscape would take a cutting-edge turn.

The players in the patient lateral transfer market include McAuley Medical, Inc., Patient Positioning Systems LLC, HoverTech International, Stryker Corporation (Sage Products LLC), Getinge AB (ArjoHuntleigh), EZ Way, Airpal, Inc., Arjo, Medline Industries, Haines Medical Australia, Sizewise, and Prism Medical.

FMI’s report offers incisive insights on the key strategies of leading and tier II patient lateral transfer market players.

A detailed analysis of business and product strategies is offered in the report.

Request Report Methodology:https://www.futuremarketinsights.com/request-report-methodology/rep-gb-12381

Key Segments of Patient Lateral Transfer Industry Survey

Patient Lateral Transfer Market by Product:

  • Air-assisted Transfer Devices
  • Slide Sheets
  • Transfer Accessories

Patient Lateral Transfer Market by Usage:

  • Single Patient Use
  • Reusable

Patient Lateral Transfer Market by End Use:

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centres

Patient Lateral Transfer Market by Region:

  • North America Patient Lateral Transfer Market
  • Latin America Patient Lateral Transfer Market
  • Europe Patient Lateral Transfer Market
  • East Asia Patient Lateral Transfer Market
  • South Asia & Pacific Patient Lateral Transfer Market
  • Middle East & Africa (MEA) Patient Lateral Transfer Market

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Acetaminophen API Market will surpass US$ 1,648.2 Million by 2033

Acetaminophen API Market
Acetaminophen API Market

The global acetaminophen API market is projected to cross US$ 1,180.4 million in 2023 and is estimated to attain a valuation of US$ 1,648.2 million by 2033. The acetaminophen API industry share is expected to thrive at a CAGR of 3.4% from 2023 to 2033.

Acetaminophen is a popular over-the-counter and prescription medication for reducing temperature and relieving pain. The demand for painkillers like paracetamol is rising as the world’s population continues to age and becomes larger. Medication availability and affordability have increased as a result of developing healthcare systems and increasing expenditures on healthcare in several countries. Because of this, there is now more demand for prescription drugs like paracetamol.

Get Recently Updated Report of Market as Sample Copy: https://www.futuremarketinsights.com/reports/sample/rep-gb-12465

Globally, chronic illnesses, including arthritis, back pain, and headaches, are on the rise. The demand for the API is further increased by the frequent use of paracetamol as first-line therapy for these diseases.  The pharmaceutical industry is expanding rapidly globally. Pharmaceutical firms’ geographic and manufacturing capacity growth has influenced the upsurge in demand for acetaminophen API.

In many pharmacological formulations, including cold and flu medications, acetaminophen is often combined with additional active components. Acetaminophen’s marketability as an API enables it to be included in other therapeutic formulations, increasing its potential. Governmental and regulatory agencies greatly influence the pharmaceutical market. Favorable rules and policies governing medication safety, efficacy, and accessibility aid the growth of the acetaminophen API industry.

North America is predicted to dominate the market during the forecast period. Factors such as rising healthcare expenditure and the growing availability of affordable throughout the region foster growth in the market. Additionally, increasing cases of cardiovascular diseases amplify the demand for effective analgesics, which further promotes market growth.

Key Takeaways from Acetaminophen API industry Report:

  • In 2018, the global market size stood at US$ 1,039.1 million.
  • The market expanded at a CAGR of 2.1% from 2018 to 2022.
  • In 2022, the global market size stood at US$ 1,150.2 million.
  • North America captured 33.4% of global market shares in 2022.
  • China captured 4.6% of global market shares in 2022.
  • Japan captured 5.2% of global market shares in 2022.
  • The United Kingdom captured 3.8 global market shares in 2022.
  • The pharmaceutical industry segment under end-user captured 38.60% of global market shares in 2022.
  • The acetaminophen injection segment acquired 31.40% of global market shares in 2022.

Elevate Your Awareness With Our Enlightening Methodology Insights: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-12465

Recent Developments Observed by FMI:

  • Genexa unveiled the first-ever clean adult acetaminophen painkiller products in May 2022. The active components and dosages of Genexas Acetaminophen Extra Strength and Acetaminophen PM caplets are the same as those of the market leaders despite the absence of artificial colors, synthetic fillers, and other artificial preservatives.
  • In April 2023, Haleon, a multinational consumer healthcare firm, launched its first analgesic from organic ingredients thanks to WhiteGrey’s marketing. PanaNatra is the first item in a new ‘naturals’ subcategory from the producers of Panadol, and it debuted with the marketing slogan ‘Who Said Natural Hasn’t Got What It Takes?

Key Players in the Global Market:

  • BOC Sciences
  • Tianjin Bofa Acetaminophen
  • Mallinckrodt plc
  • Kemcolour International
  • Chnagshu Huagang Acetaminophen
  • Haohua Industry
  • Kangle Acetaminophen
  • Angene International Limited
  • Anhui BBCA Acetaminophen
  • Granules India
  • Hebei Jihgeng Acetaminophen

Act Now to Explore In-Depth Market Analysis: Purchase Now to Access Industry Trends: https://www.futuremarketinsights.com/checkout/12465

Acetaminophen API industry Segmentation:

By Type:

  • Veterinary Drug Grade Acetaminophen API
  • Acetaminophen Grade Acetaminophen API

By End User:

  • Pharmaceutical Industry
  • Research Labs
  • Educational Institutes
  • Others

By Product Form:

  • Acetaminophen Tablets (Film-coated, Extended-release)
  • Oral Acetaminophen
  • Acetaminophen Suppository
  • Acetaminophen Injection
  • Others

By Indications:

  • Antipyretic Acetaminophen APIs
  • Acetaminophen Analgesics

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • The Middle East & Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Medical Cannula Market Reveals Segmentation Insights and Future Projections Beyond 2030

Medical Cannula Market
Medical Cannula Market

The latest report from Future Market Insights projects that the medical cannulas market size will generate US$ 783.5 million in sales by 2030. The research offers a thorough study of the medical cannula market, highlighting the key factors propelling growth in over 20 countries. Comprehensive company profiles of the leading businesses in the medical cannula sector are also included in the research.

The study predicts that during the course of the projection period, the growing preference for minimally invasive procedures will likely fuel market expansion. Manufacturers are concentrating on introducing reasonably priced, yet secure items onto the market after realising the prospects.

Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-1057

 Key Players :

  • Boston Scientific Corporation
  • Medtronic plc.
  • Becton, Dickinson and Company
  • Teleflex Incorporated
  • Conmed Corporation
  • Stryker Corporation
  • B. Braun Melsungen
  • Terumo Corporation
  • Smith & Nephew
  • Getinge Group

Advancement in technology is being tried out by medical cannula market players. For instance – bi-flow cannulation is being put into practice to facilitate simultaneous distal and systemic perfusion.

In terms of material, Arthroscopic Innovations LLC, in the year 2019, developed super-V cannula for arthroscopy. Nitinol (alloy of nickel and titanium) is used to manufacture this cannula. The distinct features include being small, superelastic, and less traumatic.

Covid-19 Impact on Medical Cannula Landscape

The impact of COVID-19 is being felt by medical cannula industry. However, as compared to other industries, the impact has been milder, as healthcare is an essential service.

The decline from hospitals has been compensated to a certain extent by homecare settings, but medical cannula manufacturers will be hoping for a quick recovery in 2021.

Key Takeaways of Medical Cannula Market Study  

  • IV cannula accounts for nearly 75% revenue share of the medical cannula market
  • Vascular access will consistently hold 30% revenue share during the assessment period
  • 18G size is expected to account for close to 50% of market share followed by 20G size
  • North America holds the largest revenue share due to novel product launches and approvals

“New product launches backed by technological advancements are expected to propel the medical cannula market” says the FMI analyst

Acquisition: Key Strategy adopted by Market Players

Inorganic growth strategies like acquisitions are emphasized by key players to substantiate themselves in the medical cannula market.

For instance –

  • In Feb 2020, IWG High-Performance Conductors (HPC) was acquired by Teleflex Medical OEM to facilitate the latter’s expansion with regard to treatments for neurovascular ailments
  • In Apr 2018, LivaNova announced acquiring Tandem Life to complement its portfolio with percutaneous mechanical circulatory support and extracorporeal life support solutions.
  • In Dec 2018, Cook Medical LLC acquired the R.J. Reynolds building at Winston-Salem’s Whitaker Park to convert it into a medical device manufacturing facility

Request Report Methodology:https://www.futuremarketinsights.com/request-report-methodology/rep-gb-1057

Key Segments:

Medical Cannula Market by Product:

  • Guedel
  • Yankauer
  • Berman
  • Frazier
  • Spackmann
  • Barron
  • Novak
  • Poole
  • Robertazzi
  • Bellucci
  • Brackman
  • Karman
  • Others

Medical Cannula Market by Medical Procedure:

  • Vascular Access
  • Surgery
  • Intubation
  • Lipofilling
  • Suction
  • Irrigation
  • Biopsy
  • Insufflation
  • Hysterography
  • Insemination
  • Cardioplegia

Medical Cannula Market by Size:

  • 14G Medical Cannulas
  • 16G Medical Cannulas
  • 18G Medical Cannulas
  • 20G Medical Cannulas
  • 22G Medical Cannulas
  • 24G Medical Cannulas
  • 26G Medical Cannulas

Medical Cannula Market by Material:

  • Latex Medical Cannulas
  • Latex-free Medical Cannulas
  • Neoprene Medical Cannulas

Medical Cannula Market by End User:

  • Hospitals
  • Ambulatory Surgical Center
  • Clinics
  • Others

Medical Cannula Market by Region:

  • North America Medical Cannula Market
  • Latin America Medical Cannula Market
  • Europe Medical Cannula Market
  • East Asia Medical Cannula Market
  • South Asia & Pacific Medical Cannula Market
  • Middle East & Africa (MEA) Medical Cannula Market

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Medical Hyperspectral Imaging Market Targets a Noteworthy US$ 294.7 Million Goal by 2030

Medical Hyperspectral Imaging Market
Medical Hyperspectral Imaging Market

Sales of medical hyperspectral imaging market size are projected to reach US$ 294.7 million by 2030, growing at a compound annual growth rate (CAGR) of 6.2% from US$ 181.8 million in 2022.

The panorama of medical imaging is continuing to evolve due to an increasing number of healthcare illnesses. Computational capacity, image analysis, and hyperspectral cameras are hence the technological advancements being used in the healthcare sector.

Non-invasive diseases as well as surgeries are being precisely figured out by imaging sensors. Also, they do not emit any sort of radiation to harm the patient or operator. According to FMI’s analysis, these factors will provide impetus to the market during the assessment period.

Get a Sample Copy of the Report :
https://www.futuremarketinsights.com/reports/sample/rep-gb-12369

List of Key Players Covered in Medical Hyperspectral Imaging market are:

  • IMEC
  • Norsk Elektro Optikk
  • Galileo
  • Gilden Photonics
  • Resonon
  • XIMEA
  • Gooch & Housego
  • Chemlmage
  • Applied Spectral Imaging
  • Cubert
  • EVK DI Kerschhaggl
  • Headwall Photonics
  • FluxData

“Proven success in North America and Europe is prompting medical hyperspectral imaging market players to shift their priorities to the developing economies. This factor will help in growth of the market between 2020 and 2030” – FMI Analyst

Key Takeaways :

  • Hyperspectral camera holds the largest market share owing to latest advancements with respect to sensor development
  • High preference for accuracy to boost prospects of MHSI in healthcare
  • US and Europe to collectively account for nearly 40% revenue share
  • India’s growth as a medical tourism hub to create opportunities for market players

Although FMI’s report is bullish on the use of hyperspectral imaging in medical applications, initial investments and reluctance to experiment will lead to limited adoption, especially in the next couple of years.

FMI’s discussion with stakeholders across the value chain revealed that concerns related to data storage, and the subsequent associated cost has been a key restraint for end-users. Many providers are offering cloud-based storage options, and it is likely that over the course of the forecast period, adoption will gradually increase.

Hyperspectral imaging used in a range of sectors apart from healthcare. The key hyperspectral imaging players are continuously focusing on offering technologically-superior products, not just for the healthcare industry.

According to FMI, holistic advances in hyperspectral imaging will boost the confidence of healthcare industry and fuel adoption. However, manufacturers will need to maintain that elusive balance between quality offerings and competitive pricing.

Request Report Methodology:https://www.futuremarketinsights.com/request-report-methodology/rep-gb-12369

Want more insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2030. The global medical hyperspectral imaging market is segmented in detail to cover every aspect and present a complete market intelligence approach to the reader.

The study provides compelling insights on medical hyperspectral imaging market on the basis of product type (healthcare hyperspectral cameras, accessories), application (medical diagnostics (ophthalmology, wound diagnostics, oncology, GI Diseases, others)), tissue and cell biology, drug discovery, others), technology (Visible Hyperspectral Imaging, Near-Infrared Hyperspectral Imaging, Ultraviolet Hyperspectral Imaging, Short-Wave Infrared Imaging, and Mid-Wave Infrared Hyperspectral Imaging), end-user (diagnostic centres, hospitals, research & academic centres, pharmaceutical & biotechnology companies) across seven regions.

Key Regions Covered:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Pacific
  • Middle East & Africa (MEA)

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Angiography Devices Market is set to achieve a value of US$ 23,309.3 Million by 2033

Angiography Devices Market
Angiography Devices Market

The global angiography devices market growth is expected to reach a valuation of US$ 12,717.9 million in 2023, to expand at a strong year-on-year growth rate of 6.2%. The global sales of angiography devices are predicted to reach a remarkable sum of about US$ 23,309.3 million by the end of 2033.

Angiography devices are becoming necessary tools for medical practitioners since they can view and diagnose a variety of cardiovascular diseases. Their uses are also broadening currently, ranging from the diagnosis of coronary artery disease to the direction of interventional operations like angioplasty and stent implantation.

Get your Sample Report with Latest Market Information: https://www.futuremarketinsights.com/reports/sample/rep-gb-1186

The growing requirement for accurate diagnoses, digital imaging technology, and improved treatment planning also fuels the demand for angiography equipment. Technological progress, which allows for more precision, better image quality, and increased patient safety, are also responsible for its growing adoption to some degree.

The overall market size is anticipated to increase in the coming days with the increased prevalence of cardiovascular illnesses and the aging population. The rising awareness of preventive healthcare practices and the necessity of early illness identification is also aiding the global market’s growth trajectory.

Key Takeaways from the Angiography Devices Industry Study Report:

  • The market for angiography devices is very prevalent in important areas of North America and Europe. In 2022, these two regions contributed almost 37.2% and 28.1% of the total revenue generated by the market globally.
  • The United States is home to prominent medical device manufacturers with developed healthcare infrastructure and supportive government policies, which contribute to its higher market share. In 2022, this region alone created 34.1% of the global demand for angiography devices.
  • Germany dominated the overall market in Europe and held a global market share of 8.2% by the end of 2022. Meanwhile, the market in the United Kingdom is forecasted to record a higher CAGR of 5.9% over the next ten years.
  • The demand for angiography procedures and devices in Asia Pacific countries is developing strongly. China, for instance, is poised to witness a robust CAGR of 8.3% in sales of angiography devices during the forecast years.

Competitive Landscape for the Angiography Devices Industry Players:

  • Abbott Vascular (Abbott Laboratories)
  • Toshiba Medical Systems Corporation
  • Royal Philips Electronics
  • GE Healthcare
  • Medtronic
  • Cordis Corporation
  • Shimadzu Corporation
  • Siemens Healthcare.

The market competition is intensifying with ongoing technical innovation and an increasing field of application. Emerging market layers are eagerly targeting smaller end users to penetrate the market and scale their business.

Explore The Art of Informed Decision-Making Via Our Methodology: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-1186

Recent Developments by the Angiography Devices Manufacturing Industries:

  • According to Canon Medical Systems USA, Incorporation, its new Aplio i900 angiography system was released for sale in February 2023. It is a high-performance angiography system and is perfect for use in various clinical settings, including interventional radiology suites and vascular surgery departments.
  • The new Siemens Healthineers Artis icono angiography system was released in March 2023. It is a small and portable angiography device, and its miniaturized features make it perfect for mobile cath laboratories and remote healthcare centers.

Key Segments Covered in the Angiography Devices Industry Report:

Angiography Devices Industry by Device:

  • Magnetic Resonance Angiography (MRA) Devices
  • Computed Tomography Angiography (CTA) Devices
  • Conventional Angiography Devices
  • Digital Subtraction Angiography (DSA) Devices
  • Catheter Angiography Devices
  • Coronary Angiography Devices
  • Other Angiography Devices

Angiography Devices Industry by Procedure:

  • Coronary Angiography
  • Pulmonary Angiography
  • Cerebral Angiography
  • Extremity Angiography
  • Renal Angiography

Angiography Devices Industry by Indication:

  • Coronary Artery Disease (CAD)
  • Congenital Heart Disease
  • Congestive Heart Failure
  • Kidney Disorders
  • Other Indications

Angiography Devices Industry by End User:

  • Hospitals and Surgical Centres
  • Diagnostics Centres
  • Academic and Research Institutes

Angiography Devices Industry by Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa Angiography Devices Industry

Act Now to Explore In-Depth Market Analysis: Purchase Now to Access Industry Trends: https://www.futuremarketinsights.com/checkout/1186

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube